AI assistant
Telefonica S.A. — Capital/Financing Update 2020
Jan 28, 2020
1889_rns_2020-01-28_60d7d9a1-2db1-43d1-8927-c40458441044.html
Capital/Financing Update
Open in viewerOpens in your device viewer
National Storage Mechanism | Additional information
You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.
RNS Number : 0742B
Telefonica SA
27 January 2020
TELEFÓNICA, S.A. in compliance with the Securities Market legislation, hereby communicates the following
RELEVANT INFORMATION
Today, TELEFÓNICA, S.A., through its wholly-owned subsidiary TELEFÓNICA EMISIONES, S.A.U., has launched in the Euro market under its Guaranteed Euro Programme for the Issuance of Debt Instruments (EMTN Programme) an issuance of Notes guaranteed by TELEFÓNICA, S.A. amounting to 1,000 million euros.
These Notes are due on February 3, 2030 pay an annual coupon of 0.664% and are issued at par (100%). The settlement and closing date is scheduled for February 3, 2020. Application will be made for the Notes to be listed on the regulated market of The Irish Stock Exchange plc trading as Euronext Dublin.
Madrid, 27 January, 2020
Legal Notice
"This announcement is neither an offer to sell nor a solicitation of an offer to buy any of the securities referred to herein and shall not constitute an offer, solicitation nor sale in any jurisdiction in which such offer, solicitation or sale is unlawful -including but not limited to the United States, Australia, Canada or Japan-.
The securities referred to herein have not been and will not be registered under the United States Securities Act of 1933, as amended, or any state securities laws, and may not be offered or sold in the United States absent registration or pursuant to an exemption from the registration requirements of the Securities Act and in accordance with applicable state securities laws."
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
END
ISEEANFXAEPEEFA